DigiCon

What is the incidence per month of the below metabolic disorders in your clinical practice? *

Number of patients	<10	10-20	21-30	31-40	>40
Hypertension
Diabetes
Dyslipidemia

In which age group do you find the maximum prevalence of the following metabolic disorders? *

Age group	<30 years	30-40 years	40-50 years	51-75 years	>75 years
Hypertension
Diabetes
Dyslipidemia

In which gender do you find high prevalence of the below metabolic disorders? *

a. Hypertension

Males

Females

No difference

b. Diabetes

Males

Females

No difference

c. Dyslipidemia

Males

Females

No difference

What percentage of patients with following metabolic disorders also have hyperuricemia in your clinical practice? *

Percentage	<20%	21-30%	31-40%	>40%
Hypertension
Diabetes
Dyslipidemia

In which age group of patients with metabolic disorders you find high prevalence of hyperuricemia? *

Age group	<30 years	30-40 years	40-50 years	51-75 years	>75 years
Hypertension
Diabetes
Dyslipidemia

Is there any gender difference in the below mentioned patient group? *

Diabetic patients with hyperuricemia

Males are affected more

Females are affected more

No Difference

Hypertensive patients with hyperuricemia

Males are affected more

Females are affected more

No Difference

Dyslipidemia patients with hyperuricemia

Males are affected more

Females are affected more

No Difference

At what uric acid level, do you treat your patients with below metabolic disorders for hyperuricemia? *

Hypertension
Diabetes mellitus
Dyslipidemia

Mention your preferred treatment regimen for symptomatic hyperuricemic patients with the below Metabolic Disorders? *

Hypertension
Diabetes mellitus
Dyslipidemia

What percentage of your patients with the below metabolic disorders are currently undergoing treatment for symptomatic hyperuricemia on the below specified drugs? *

Hypertension
Febuxostat	< 40%	40-60%	61-80%	>80%
Allopurinol	< 40%	40-60%	61-80%	>80%
Probenecid	< 40%	40-60%	61-80%	>80%
Colchicine	< 40%	40-60%	61-80%	>80%
Topiroxostat	< 40%	40-60%	61-80%	>80%

Diabetes
Febuxostat	< 40%	40-60%	61-80%	>80%
Allopurinol	< 40%	40-60%	61-80%	>80%
Probenecid	< 40%	40-60%	61-80%	>80%
Colchicine	< 40%	40-60%	61-80%	>80%
Topiroxostat	< 40%	40-60%	61-80%	>80%

Dyslipidaemia
Febuxostat	< 40%	40-60%	61-80%	>80%
Allopurinol	< 40%	40-60%	61-80%	>80%
Probenecid	< 40%	40-60%	61-80%	>80%
Colchicine	< 40%	40-60%	61-80%	>80%
Topiroxostat	< 40%	40-60%	61-80%	>80%

Rate the following drugs used to control symptomatic hyperuricemia as per your clinical experience? *

Drugs	Hypertension	Diabetes	Dyslipidemia
Febuxostat
Allopurinol
Probenecid
Colchicine

What is your preferred dose to treat symptomatic hyperuricemia in your practice? *

	Febuxostat (Dose in mg)	Allopurinol (Dose in mg)	Probenecid (Dose in mg)	Colchicine (Dose in mg)	Topiroxostat (Dose in mg)
Hypertension
Diabetes
Dyslipidemia

What is your preferred duration of treatment for symptomatic hyperuricemia in patients with following Metabolic Disorders? *

	Febuxostat (in weeks)	Allopurinol (in weeks)	Probenecid (in weeks)	Colchicine (in weeks)	Topiroxostat (in weeks)
Hypertension
Diabetes
Dyslipidemia

As per your clinical experience rate the safety profile for below mentioned urate lowering drugs? *

Febuxostat
Allopurinol
Probenecid
Colchicine
Topiroxostat

What % of CKD patients you observe in your clinical practice? *

<10%

11-30%

>30%

Out of all the CKD patients you observe what percentage are Hyperuricemic? *

<10%

11-25%

26-50%

>50%

In your practice have you observed renoprotective effects of febuxostat in CKD patients with gout? *

Yes

No

What lifestyle modification do you recommend to a symptomatic hyperuricemia patient with hypertension? (Check all that apply) *

Regular exercise

Limiting alcohol consumption

Quit smoking

Healthy diet rich in fruits, vegetables etc.

Any Other

What lifestyle modification do you recommend to a symptomatic hyperuricemia patient with dyslipidemia? (Check all that apply) *

Consume diet low in saturated and trans fats

Regular exercise

Consume Omega-3 fatty acids

Limit alcohol consumption

Any Other

What lifestyle modification do you recommend to a symptomatic hyperuricemia patient with diabetes mellitus? (Check all that apply) *

Regular exercise

Manage stress

Quit smoking

Diet rich in vegetables, fruits, whole grains but limiting foods that are high in sugar and fat

Limit alcohol consumption

Any Other

In following metabolic disorder patients with controlled uric acid levels, do you continue treatment? *

	Yes	No
Hypertension
Diabetes
Dyslipidemia

What is the adherence rate for the prescribed therapy in symptomatic hyperuricemia patients with following metabolic disorders in your clinical practice? *

	<50%	50-70%	71-90%	>90%
Hypertension
Diabetes
Dyslipidemia

As per your clinical experience what are the factors for poor compliance to therapy for symptomatic hyperuricemia? (Check all that apply) *

Cost of therapy

Availability of drugs

Dosage

Unfavorable safety

Any Other

As per recent study febuxostat is more effective than allopurinol in lowering serum urate. What is your clinical experience between these two drugs in terms of lowering serum urate? *

Recent clinical evidences have shown febuxostat is not associated with increasing risk of adverse cardiovascular events compared to allopurinol. What do you think about CV safety of febuxostat Vs allopurinol? *

Febuxostat increases CV risk more than allopurinol

Febuxostat does not increase CV risk

CV risk with febuxostat is lesser than allopurinol

Latest study demonstrated favorable renal safety of febuxostat and good urate lowering efficacy in gout patients with stage 4-5 CKD. What is your clinical experience about febuxostat in gout patients with severe renal impairment? *

Renal safety of febuxostat

Febuxostat has unfavorable renal safety

Febuxostat has favorable renal safety

Any Other

Urate lowering efficacy of febuxostat

Febuxostat decreases serum uric acid significantly

Febuxostat does not decrease serum uric acid significantly

In your clinical practice what is the maintenance dose of febuxostat in the management of symptomatic hyperuricemia and gout? *

What is your treatment approach when maximum tolerated dose of febuxostat does not work in the management of symptomatic hyperuricemia and gout? *

{{ $ActivityTypeName }}

To understand Correlation between Hyperuricemia and Metabolic Disorders in Indian Patients

(CHEC-MED)

Doctor’s details